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In mammalian cells, nonsense-mediated mRNA de-
cay (NMD) generally requires that translation termi-
nates sufficiently upstream of a post-splicing exon
junction complex (EJC) during a pioneer round of
translation. The subsequent binding of Upf1 to the
EJC triggers Upf1 phosphorylation. We provide evi-
dence that phospho-Upf1 functions after nonsense
codon recognition during steps that involve the
translation initiation factor eIF3 and mRNA decay
factors. Phospho-Upf1 interacts directly with eIF3
and inhibits the eIF3-dependent conversion of 40S/
Met-tRNAi
Met/mRNA to translationally competent
80S/Met-tRNAi
Met/mRNA initiation complexes to re-
press continued translation initiation. Consistentwith
phospho-Upf1 impairing eIF3 function, NMD fails to
detectably target nonsense-containing transcripts
that initiate translation independently of eIF3 from
the CrPV IRES. There is growing evidence that trans-
lational repression is a key transition that precedes
mRNA delivery to the degradationmachinery. Our re-
sults uncover a critical stepduringNMD that converts
a pioneer translation initiation complex to a transla-
tionally compromised mRNP.
INTRODUCTION
NMD plays an important role in the posttranscriptional control of
human gene expression. Approximately 75% of human genes
generate pre-mRNAs that undergo alternative splicing, and
more than one-third of alternatively spliced transcripts are tar-
geted for elimination by the NMD pathway (Lewis et al., 2003).
Most alternatively spliced NMD targets appear to be generated
in error (Pan et al., 2006). However, NMD also downregulates314 Cell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc.the level of other transcripts that are productive, including those
that harbor upstream open reading frames, contain a UGA sele-
nocysteine codon, or are autoregulated by the encoded protein
(see, e.g., Mendell et al., 2004; Wittmann et al., 2006; Ni et al.,
2007).
As a rule, NMD in mammals degrades newly synthesized
mRNAs during a pioneer round of translation, which utilizes
mRNA that is associated with the cap-binding protein (CBP) het-
erodimer CBP80/20 and may involve the loading of more than
one ribosome (Ishigaki et al., 2001; Lejeune et al., 2002; Chiu
et al., 2004; Lejeune et al., 2004; Hosoda et al., 2005; Kashima
et al., 2006). The pioneer round precedes subsequent rounds
of translation that utilize mRNA that is bound at its cap by eukary-
otic translation initiation factor (eIF)4E. eIF4E-bound mRNA,
which is the remodeled product of CBP80/20-bound mRNA,
supports the bulk of cellular protein synthesis (Pestova et al.,
2007; Lejeune et al., 2002). NMD generally occurs when transla-
tion during a pioneer round terminates more than 50–55 nucle-
otides upstream of a splicing-generated exon-exon junction
(Isken and Maquat, 2007). The role of exon-exon junctions in
NMD reflects the splicing-dependent deposition of an exon junc-
tion complex (EJC) of proteins 20–25 nucleotides upstream of
junctions (Le Hir et al., 2001). The EJC consists of NMD factors
Upf3 (also called Upf3a) or Upf3X (also called Upf3b), Upf2,
and, presumably after translation terminates sufficiently up-
stream of the EJC, Upf1 (Kashima et al., 2006; Kim et al.,
2001), which also associates with the CBP80/20 cap-binding
complex (Hosoda et al., 2005). According to a current model,
translation termination depends on the joining of the PIK-related
protein kinase SMG-1 and Upf1 with the two translation termina-
tion factors eRF1 and eRF3 to form SURF (Kashima et al., 2006).
If an EJC exists sufficiently downstream of the termination event,
then SMG-1 and Upf1 binding to that EJC triggers Upf1 phos-
phorylation (Kashima et al., 2006; Wittmann et al., 2006). Upf1
phosphorylation leads to formation of the so-called decay-in-
ducing complex (Kashima et al., 2006), and decay is initiated
from either or both mRNA ends (Lehner and Sanderson, 2004;
Lejeune et al., 2003; Lykke-Andersen, 2002; Unterholzner and
Izaurralde, 2004; Yamashita et al., 2005). In comparison to
CBP80/20-bound mRNA, eIF4E-bound mRNA lacks detectable
EJCs and appears to be immune to NMD (Chiu et al., 2004;
Hosoda et al., 2005; Ishigaki et al., 2001; Lejeune et al., 2002;
Matsuda et al., 2007).
There is growing evidence that mRNA decay in eukaryotes re-
quires an exit from translation so that the mRNA is accessible to
degradative activities. For example, in Saccharomyces cerevi-
siae, eIF4E and the poly(A) binding protein inhibit decapping at
least in part through their roles as general translational activators
(Coller and Parker, 2004). Also inS. cerevisiae, Dhh1p and Pat1p,
which target cytoplasmic mRNAs for decapping and facilitate
their assembly into processing (P) bodies in response to glucose
deprivation or amino acid starvation, have been shown to be
general activators of translational repression (Coller and Parker,
2005). In mammalian cells, binding of the translational repressor
TIAR to the 30 untranslated region (UTR) of GADD45a mRNA,
which is induced upon growth arrest or DNA damage, results
in GADD45a mRNA translational repression and decay that is
mediated by AUF-1 association with the 30 UTR (Lal et al.,
2006). Also in mammalian cells, 4E-transporter binding to
eIF4E downregulates cap-dependent translation in a way that
primes mRNA for localization to P bodies and decay (Ferraiuolo
et al., 2005). More directly pertinent to the studies reported here,
translational repression occurs in S. cerevisiae, although by an
unknown mechanism, after nonsense codon recognition during
the process of NMD (Muhlrad and Parker, 1999; Sheth and
Parker, 2006). It follows that translational repression would
likewise accompany NMD in mammalian cells.
In this report, we provide evidence that translational repression
does indeed occur during NMD in mammalian cells. Since the
trigger for decay appears to be the phosphorylation of Upf1, we
first identified NMD factors that preferentially coimmunoprecipi-
tate with wild-type (WT) Upf1, which is primarily hypophosphory-
lated (Pal et al., 2001; Yamashita et al., 2001), or either a mutated
variant of Upf1 or WT Upf1 from okadaic acid (OA)-treated cells,
each of which manifests a higher degree of phosphorylation than
WT Upf1 from untreated cells. We found that WT Upf1 from un-
treated cells has a significantly higher affinity than hyperphos-
phorylated (phospho-) Upf1 for SURF constituents SMG-1 and
eRF3. These interactions are thought to take place prior to or dur-
ing nonsense codon recognition (Kashima et al., 2006). We also
discovered that phospho-Upf1 has a significantly higher affinity
for the NMD degradative factors Dcp1a, Xrn1, and Rrp4. Accord-
ing to current models, these interactions occur after nonsense
codon recognition. Remarkably, phospho-Upf1 also preferen-
tially interacts with the eIF2-GTP-Met-tRNAi
Met ternary transla-
tion initiation complex via eIF3. We present a model in which
the SMG-1-mediated Upf1 phosphorylation that occurs upon
SMG-1 and Upf1 binding to an EJC triggers eIF3-dependent
translational repression and mRNA decay. Consistent with this
model, we find that phospho-Upf1 targets the translation initia-
tion process by inhibiting the eIF3-dependent conversion of
40S/Met-tRNAi
Met/mRNA to translationally competent 80S/
Met-tRNAi
Met/mRNA. Furthermore, CrPV IRES-mediated trans-
lation initiation, which is eIF3 independent, does not detectably
support NMD, whereas EMCV IRES-mediated translation initia-
tion, which is eIF3 dependent, does.RESULTS
WTUpf1 and Phospho-Upf1Manifest Different Affinities
for mRNP Proteins
Upf1 is a phosphoprotein (Pal et al., 2001), and Upf1 phosphor-
ylation has been shown to influence Upf1 binding to SMG-5,
SMG-7, protein phosphatase 2A, Upf2, and distinct isoforms of
Upf3 (Kashima et al., 2006; Ohnishi et al., 2003). Upf1 phosphor-
ylation by SMG-1 is essential for NMD (Brumbaugh et al., 2004;
Yamashita et al., 2001), takes place upon Upf1 and SMG-1 bind-
ing to an EJC after translation terminates sufficiently upstream of
the EJC (Kashima et al., 2006), and is promoted by EJC compo-
nents (Kashima et al., 2006; Wittmann et al., 2006). We aimed to
define which steps of NMD involve phosphorylated Upf1.
Initially, HeLa cells were transiently transfected with one of two
pCMV-myc-UPF1R plasmids, each of which produces Upf1 that
is resistant to an siRNA (the particular use of which is important in
subsequent experiments). One plasmid, WT, encodes unmu-
tated Upf1, which is primarily hypophosphorylated (Pal et al.,
2001; Yamashita et al., 2001). The other plasmid, G495R/
G497E, encodes Upf1 harboring amino acid substitutions at po-
sitions 495 and 497 within the ATPase/RNA helicase domain.
These substitutions are predicted from studies of Upf1 in Caeno-
rhabiditis elegans to result in inefficient Upf1 dephosphorylation
and, therefore, hyperphosphorylated (phospho)-Upf1 (Page
et al., 1999). Two days after transfection, cells were lysed. Pro-
tein was analyzed before and after immunoprecipitation (IP) us-
ing anti-myc or, to control for nonspecific IP, mouse (m)IgG.
Each myc-Upf1R derivative was produced in HeLa cells at
a comparable level (Figure 1A, lanes 1 and 2, WB: a-myc), and
this level was less than 2-fold above the level of endogenous
HeLa cell Upf1 (Figure 1A, lanes 1 and 2, WB: a-Upf1). Further-
more, each myc-Upf1R derivative was immunoprecipitated
with comparable efficiency using anti-myc (Figure 1A, lanes 4
and 6, WB: a-Upf1 or a-myc), and neither was immunoprecipi-
ated using mIgG (Figure 1A, lanes 3 and 5, WB: a-Upf1 or
a-myc).
Using samples after IP, myc-Upf1R(G495R/G497E) was con-
firmed to be hyperphosphorylated relative to myc-Upf1R(WT)
as indicated by the 4- to 5-fold higher reactivity of anti-phos-
pho(S/T)Q with myc-Upf1R(G495R/G497E) relative to myc-
Upf1R(WT) (Figures 1A, lanes 4 and 6, WB: a-p(S/T)Q;
Figure S1A available online) that was not detectable upon phos-
phatase treatment (Figure S1A). SMG-1 and eRF3 preferentially
immunoprecipitated with myc-Upf1R(WT) compared to myc-
Upf1R(G495R/G497E) (Figure 1A, lanes 4 and 6, WBs: a-SMG-
1 and a-eRF3). By contrast, the EJC core constituent eIF4AIII
manifested a very slight preference for myc-Upf1R(G495R/
G497E) compared to myc-Upf1R(WT) (Figure 1A, lanes 4 and
6, WB: a-eIF4AIII), and degradative activities known to function
in NMD, including the decapping activator Dcp1a, the 50-to-30
exonuclease Xrn1, and the exosomal component Rrp4, ex-
hibited appreciable preference for myc-Upf1R(G495R/G497E)
(Figure 1A, lanes 4 and 6, WBs: a-Dcp1a, a-Xrn1, and a-Rrp4).
The weak interaction of Upf1 with eIF4AIII probably reflects its
very transient nature. As a negative control, Calnexin was not
detectably immunoprecipitated under any condition (Figure 1A,
lanes 3–6, WB: a-Calnexin). The preferential affinities of SMG-1Cell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc. 315
Figure 1. WT Upf1 Preferentially Interacts with SMG-1 and eRF3, whereas Phospho-Upf1 Preferentially Interacts with mRNA Decay Factors
(A) HeLa cells (3–43 107) were transiently transfected with pCMV-myc-UPF1R(WT) or pCMV-myc-UPF1R(G495R/G497E) (10 mg). Two days later, total-cell lysate
was immunoprecipitated using anti(a)-myc or mouse (m)IgG. Western blotting (WB) was performed using the specified antibodies. The four leftmost lanes an-
alyzed decreasing amounts of protein before () IP.
(B) Essentially as in (A), except cells were transiently transfected with pCMV-myc-UPF1R(WT) and treated with the specified amount of OA for 3 hr prior to harvest-
ing. All results are representative of three independently performed experiments.for hypophosphorylated Upf1 and of mRNA degradative activi-
ties and, to a very slight extent, eIF4AIII for phospho-Upf1
were corroborated by treating HeLa cells transiently expressing
myc-Upf1(WT) with 0, 50, or 75 nM OA prior to IP (Figure 1B,
lanes 5, 7, and 9). OA is a potent inhibitor of protein phosphatase316 Cell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc.2A (Haystead et al., 1989) that results in the accumulation of
phospho-Upf1 (Figure 1B, lanes 7 and 9; Figure S1B).
Our findings indicate that hypophosphorylated Upf1 preferen-
tially interacts with mRNP constituents at steps that are thought
to precede or occur during translation termination. In contrast,
phospho-Upf1 preferentially interacts with mRNP constituents,
presumably largely during the pioneer round of translation, at
steps that are envisioned to take place after translation termina-
tion, including the recruitment of mRNA decay factors.
Upf1 Decreases Cap-Dependent and HCV
IRES-Dependent Translation Initiation
but Not CrPV IRES-Dependent Translation Initiation
mRNAs that are targeted for decapping generally undergo trans-
lational repression (Coller and Parker, 2005). Since NMD in
mammalian cells involves decapping (Lejeune et al., 2003;
Unterholzner and Izaurralde, 2004), mRNAs that are slated for
NMD should also undergo translational repression. We hypothe-
sized that translational repression during NMD is likely to involve
phospho-Upf1 for a number of reasons. First, the trigger for NMD
is Upf1 binding to an EJC after translation terminates sufficiently
upstream of the EJC, which results in Upf1 phosphorylation
(Kashima et al., 2006; Wittmann et al., 2006; Figure 1). Second,
Upf1 remains hyperphosphorylated during subsequent steps
that include recruiting mRNA decay factors (Figure 1). Therefore,
phospho-Upf1 would be expected to exist during what we pro-
pose would be an intermediate step of translational repression.
As noted above, NMD in mammalian cells is largely if not ex-
clusively restricted to the translation of CBP80/20-bound
mRNA during a pioneer round of translation. At present, analyz-
ing NMD provides the only functional assay for this round of
translation, which constitutes only a very small fraction of cellular
translation (Ishigaki et al., 2001; Lejeune et al., 2002). However,
the pioneer translation initiation complex shares many constitu-
ents with the translation initiation complex that supports the bulk
of cellular protein synthesis, including eIF2, eIF3, eIF4G,
PABPC1, and ribosomes (Chiu et al., 2004; Hosoda et al.,
2006; Ishigaki et al., 2001; Lejeune et al., 2002, 2004). Moreover,
NMD, like the bulk of cellular translation, is inhibited by suppres-
sor tRNA, anisomysin, cycloheximide, emetine, pactamycin, and
puromycin (Isken and Maquat, 2007). Furthermore, the Upf fac-
tors have been implicated as effectors of bulk cellular translation
(see Discussion in Supplemental Data). Additionally, Upf1 binds
eRF1 and eRF3 (Czaplinski et al., 1998; Kashima et al., 2006;
Figure 1A), which function during both pioneer and subsequent
rounds of translation termination. Therefore, it is reasonable to
propose that phospho-Upf1 would affect the bulk of cellular
translation as it affects the pioneer round of translation.
Initially, we assayed for an effect of Upf1 on the bulk of cellular
translation by downregulating the cellular abundance of Upf1 us-
ing in vitro-synthesized siRNA. HeLa cells were transfected with
Upf1 siRNA or a nonspecific control siRNA (Kim et al., 2005). Two
days later, cells were retransfected with three plasmids:
a pmCMV-Gl test plasmid (Ishigaki et al., 2001) that was either
nonsense free (Norm) or contained a premature termination co-
don (39Ter), a phCMV-MUP reference plasmid (Ishigaki et al.,
2001), and a pR/HCV/F or pR/CrPV/F dual Renilla (R) and Firefly
(F) luciferase reporter plasmid (Figure 2A; Kim et al., 2005; Wilson
et al., 2000). The test plasmids provided an assay for NMD. The
reference plasmid controlled for variations in the efficiencies of
cell transfection and RNA recovery. The reporter plasmids mon-
itored the efficiencies of cap-dependent translation initiation
and, respectively, Hepatitis C Virus (HCV) internal ribosome entrysite (IRES)-dependent or Cricket Paralysis Virus (CrPV) IRES-de-
pendent translation initiation. One day after the second transfec-
tion, total-cell protein was analyzed to assess the efficiency of
Upf1 downregulation. Additionally, total-cell RNA was purified
for the analysis of individual mRNAs by RT-PCR to determine
the efficiency of NMD and the abundance of R/HCV/F or
R/CrPV/F mRNA. Cell lysates were also subjected to dual
Luciferase (Luc) activity assays.
Results of western blotting indicated that, relative to control
siRNA, Upf1 siRNA reduced the level of cellular Upf1 20-fold
(Figure 2B). Results of RT-PCR revealed that downregulating
Upf1 also inhibited the NMD of Gl 39Ter mRNA 3- to 4-fold
(Figure 2C), consistent with reports that Upf1 is essential for
NMD (Isken and Maquat, 2007).
Additionally, downregulating Upf1 increased the level of cap-
dependent or HCV IRES-dependent translation 4- to 6-fold
(Figure 2D). Downregulating Upf1 was of little consequence to
CrPV IRES-dependent translation but, again, increased the level
of cap-dependent translation (Figure 2D). Importantly, downre-
gulating Upf1 using Upf1(A) siRNA (Kim et al., 2005), which tar-
gets a different region of UPF1 mRNA than does Upf1 siRNA,
also increased the level of cap-dependent and HCV IRES-de-
pendent translation but not CrPV IRES-dependent translation
(Figure S2; data not shown for HCV IRES-dependent translation).
Therefore, the changes observed with Upf1 siRNA are not the re-
sult of off-target effects. In contrast to Upf1, neither Upf2 nor
Upf3X were found to affect any type of translation initiation
(Figures S3 and S4).
Cap-dependent and IRES-dependent translation differ in their
modes of initiation but not elongation or termination (Jackson,
2005). Therefore, our results indicate that downregulating Upf1
upregulates translation initiation but not detectably later steps
of protein synthesis. Cap-dependent translation initiation re-
quires all eIFs, HCV IRES-dependent translation initiation re-
quires eIF2 and eIF3, and CrPV IRES-dependent translation
initiation requires no eIFs (Doudna and Sarnow, 2007). There-
fore, our results suggest that Upf1 inhibits translation initiation
by targeting eIF2, eIF3, or both.
CrPV IRES-Dependent Translation Initiation
Fails to Support NMD
If Upf1 inhibits translation initiation by targeting eIF2 and/or
eIF3, then translation initiation from the CrPV IRES should not
support NMD. To test this hypothesis, plasmids were generated
(Figure 3A) that produce RLuc-Gl (R-Gl) mRNA, either Norm or
39Ter, containing the CrPV IRES or, as a positive control, the
EMCV IRES, which depends on all canonical eIFs (Doudna
and Sarnow, 2007) and supports NMD (Holbrook et al., 2006).
The EMCV IRES was chosen for analysis since its activity
in vivo can be selectively reduced by mutating the functionally
critical GCGA tetraloop (Robertson et al., 1999). This is impor-
tant since protein production from the CrPV IRES is less than
from the EMCV IRES in cycling cells (Fernandez et al., 2002;
Humphreys et al., 2005). To generate an EMCV IRES that initi-
ates translation with an efficiency comparable to the CrPV
IRES, the EMCV IRES(WT) GCGA tetraloop was mutated to
GTTA. Furthermore, a hairpin structure that blocks ribosomes
initiating at the cap was inserted upstream of each IRES toCell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc. 317
ensure that translation initiates only at the IRES (Holbrook et al.,
2006; Woeller et al., 2008). Cos cells were transiently transfected
with Control or Upf1 siRNA. Cells were subsequently transfected
with each IRES-containing construct and, to control for variations
among transfections, pcDNA FLuc and phCMV-MUP. Cos cells
were used since the activities of the EMCV IRES(GTTA) and the
CrPV IRES were more similar in Cos cells than in HeLa cells
(data not shown), and equivalent activities are critical if we aim
to compare the dependence of IRES-initiated NMD on eIF2 or
eIF3 function.
Figure 2. Downregulating the Cellular Abundance of
Upf1 Increases Cap-Dependent and HCV IRES-De-
pendent Translation but Not CrPV IRES-Dependent
Translation
(A) Schematic representations of the bicistronic constructs
that encode Renilla (R) and Firefly (F) Luciferase (Luc). HeLa
cells (23 106) were transiently transfected with Upf1 or control
siRNA. Two days later, cells were retransfected with
a pmCMV-Gl test plasmid, either Norm or 39Ter, the reference
phCMV-MUP plasmid, and a reporter plasmid that was either
pR/HCV/F or pR/CrPV/F.
(B) Western blotting (WB) was used to quantitate the level of
Upf1 relative to Vimentin.
(C) RT-PCR was used to quantitate the levels of Gl and MUP
mRNAs in transfections with either pR/HCV/F or pR/CrPV/F.
Numbers below the figure represent the level of Gl mRNA after
normalization to the level of MUP mRNA, where the normal-
ized level of Gl Norm mRNA in the presence of each siRNA
or no () siRNA was defined as 100%.
(D) Luminometry was used to quantitate FLuc and RLuc activ-
ities, which were normalized to levels of R/HCV/F or R/CrPV/F
mRNA to control for variations in transfection efficiencies. The
normalized levels of Luc activity in transfections with control
siRNA were defined as 1. Results are the average of two inde-
pendently performed experiments.
Western blotting confirmed that, relative to con-
trol siRNA, Upf1 siRNA reduced the cellular abun-
dance of Upf110-fold (Figure 3B). In the presence
of control siRNA, mutating the GCGA tetraloop to
GTTA reduced the level of EMCV IRES-mediated
translation from 100% to 15% ± 3% (Figure 3C).
CrPV IRES-mediated translation was 20% ± 4%
the level of EMCV IRES(WT)-mediated translation
(Figure 3C). The comparable strengths of the
EMCV IRES(GTTA) and CrPV IRES allowed us to
compare the efficiency of NMD elicited by each
IRES in the absence of significant differences due
to translation initiation efficiencies and, thus,
nonsense codon recognition. In the presence of
Upf1 siRNA, the detectable increase in EMCV
IRES(WT)-initiated and EMCV IRES(GTTA)-initiated
RLuc activities but not CrPV IRES-initiated RLuc
activity provided the first indication that Upf1 may
differently affect the EMCV and CrPV IRESes. RT-
PCR revealed that both EMCV IRES(WT)-initiated
translation and EMCV IRES(GTTA)-initiated trans-
lation supported NMD whereas CrPV IRES-initiated
translation did not (Figure 3D). Additionally, EMCV
IRES(WT)-supported NMD and EMCV IRES(GTTA)-supported
NMD were inhibited by Upf1 siRNA (Figure 3D). Notably, the
IRES-supported NMD of R-Gl mRNA in Cos cells was less effi-
cient than the cap-dependent NMD of Gl mRNA in HeLa cells
(compare Figure 3D to Figure 2C). The difference in efficiency
may be partly explained by the lower efficiency of IRES-medi-
ated translation initiation compared to cap-dependent transla-
tion initiation (data not shown). However, the use of different
cell types and reporter mRNAs probably also contributed to
the observed differences. We conclude that NMD requires eIF2318 Cell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc.
and/or eIF3, which is consistent with the hypothesis that Upf1
mediates translational repression by targeting one or both of
these initiation factors.
Upf1 Phosphorylation Represses Translation Initiation
Our results predict that phospho-Upf1 inhibits cap-dependent
translation more efficiently than WT Upf1 for two reasons: (1)
Upf1 becomes hyperphosphorylated just prior to when transla-
tional repression during NMD would be expected to occur, and
(2) Upf1 remains hyperphosphorylated while associated with
mRNA decay factors (Figure 1). To test this prediction, we mea-
sured the effect of phospho-Upf1 expression on translation.
HeLa cells were transiently transfected with Upf1 siRNA or con-
trol siRNA, the latter of which was used solely to determine the
efficacy of Upf1 siRNA. Two days later, cells were retrans-
fected with (1) pmCMV-Gl, either Norm or 39Ter, (2) phCMV-MUP,
(3) pR/CrPV/F, and (4) pCMV-myc, pCMV-myc-UPF1R(WT),
Figure 3. Translation Initiation from the
CrPV IRES, Unlike Translation Initiation
from the EMCV IRES, Fails to Support NMD
Cos cells (3 3 106) were transiently transfected
with control or Upf1 siRNA and, 2 days later,
with php/EMCV(WT)/R-Gl, php/EMCV(GTTA)/
R-Gl or php/CrPV/R-Gl, either Norm or 39Ter
(10 mg), pFLuc (0.5 mg), and phCMV-MUP (0.3 mg).
(A) Diagrams of each R-Gl construct. In the case of
39Ter, 39 specifies the position of the nonsense
codon.
(B) Western blotting (WB) was used to quantitate
the level of Upf1 relative to p62.
(C) Luminometry was used to quantitate RLuc and
FLuc activities. RLuc activities were normalized to
FLuc activities, to control for variations among
protein preparations, and R-Gl mRNA levels, to
control for variations in cell transfection efficien-
cies. The normalized level of RLuc activity from
php/EMCV(WT)/R-Gl in the presence of control
siRNA was defined as 100%. Error bars represent
the mean ± standard deviation (SD) of three inde-
pendently performed experiments.
(D) RT-PCR of R-Gl and MUP mRNAs. Numbers
below the figure represent the levels of R-Gl mRNA
after normalization to the level of MUP mRNA,
where the normalized level of R-Gl Norm mRNA in
the presence of each php plasmid was defined as
100%. Results are the average of three indepen-
dently performed experiments.
or pCMV-myc-UPF1R(G495R/G497E),
the latter two of which provide an siRNA-
resistant source of Upf1.
Western blotting using anti-Upf1 demon-
strated that the level of cellular Upf1 was
downregulated to 14% of normal
(Figure 4A). Furthermore, each myc-
Upf1R was indeed resistant to siRNA-me-
diated downregulation and restored the
cellular level of Upf1 to near normal
(Figure 4A). RT-PCR analysis of Gl and
MUP mRNAs revealed that in the pres-
ence of Upf1 siRNA myc-Upf1R(WT) expression resulted in
more efficient NMD than myc-Upf1R(G495R/G497E) expression
(Figure 4B). These results are expected considering that cycles
of Upf1 phosphorylation and dephosphorylation are essential to
NMD (Page et al., 1999; Sun et al., 1998; Yamashita et al.,
2001). Additionally, the increased production of cap-dependent
RLuc activity relative to CrPV IRES-dependent FLuc activity
brought about by downregulating Upf1 was inhibited more effec-
tively by myc-Upf1R(G495R/G497E) than by myc-Upf1R(WT)
(Figure 4C). Consistent with these findings, treating cells with
OA, which produces phospho-Upf1 (Figures 1B and S1B), also
inhibited NMD (Figure 4D). OA, which has been shown to inhibit
the dephosphorylation of eIF4E and increase bulk cellular trans-
lation (Bu et al., 1993), increased RLuc activity (Figure 4E) as
expected. These data suggest that phospho-Upf1 is largely
responsible for the Upf1-mediated inhibition of translation
initiation of CBP80/20-bound mRNA.Cell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc. 319
Upf1 Phosphorylation Promotes Upf1 Binding to eIF3
Since Upf1 may inhibit translation initiation by targeting eIF2 and/
or eIF3, we investigated the interaction of Upf1 with each of
these eIFs. Results demonstrated that Upf1 coimmunoprecipi-
tates with eIF3 and eIF2 (Figure S5A). However, downregulating
Upf1 was of no consequence to the phosphorylation status of
eIF2a (Figure S5B), which is important considering that phos-
phorylated eIF2a inhibits translation initiation (Proud, 2005).
Far-western analyses using eIF2 or eIF3 purified from HeLa cells
(Brown-Luedi et al., 1982) and baculovirus-produced and puri-
fied FLAG-Upf1(WT) (Hosoda et al., 2005) indicated that the in-
teraction of FLAG-Upf1 with eIF2 is likely to be indirect but the
interaction of FLAG-Upf1 with the eIF3a subunit is apt to be di-
rect (Figure S5C). Notably, FLAG-Upf1 coimmunoprecipitated
with HA-eIF2a(WT) but not detectably with HA-eIF2a(S51D)
(Figure S5D), the latter of which is an inactive phosphomimetic
Figure 4. Phosphorylated Upf1 Represses
Cap-Dependent but Not CrPV IRES-Depen-
dent Translation Initiation
(A–C) HeLa cells (1 3 106) were transiently trans-
fected with control or Upf1 siRNA. Two days later,
cells were transfected with pCMV-myc-
UPF1R(WT) or pCMV-myc-UPF1R(G495R/
G497E). (A) Western blotting (WB) was used to
quantitate the level of myc-Upf1 relative to endog-
enous Upf1 and SMG-1. (B) RT-PCR analysis of Gl
and MUP mRNAs. As in Figure 2C, except the nor-
malized levels of Gl Norm mRNA in transfections
that included each pCMV-myc expression vector
were defined as 100%. (C) Relative levels of Luc
activity.
(D and E) HeLa cells (33 106) were treated with the
specified amount of OA for 3 hr prior to harvesting.
(D) RT-PCR of Gl and MUP mRNAs. (E) Relative
RLuc activity normalized to the level of RLuc
mRNA, where the normalized level in the absence
of OA is defined as 1. Results are the average of
three independently performed experiments. Error
bars in (C) and (E) represent the mean ± SD of
three independent experiments.
variant (Kaufman et al., 1989) that cannot
recycle to form the eIF2-GTP-Met-
tRNAi
Met ternary complex (Ernst et al.,
1987). Therefore, the co-IP of FLAG-Upf1
with eIF2 is probably because FLAG-
Upf1 coimmunoprecipitates with the ter-
nary complex via its direct interaction
with eIF3.
Our finding that Upf1 interacts with
eIF3, together with data suggesting that
Upf1 phosphorylation inhibits translation
initiation, predict that phospho-Upf1
would have a higher affinity for eIF3 than
does WT Upf1. This prediction was tested
in three ways, each of which used our two
sources of phospho-Upf1. In the first test,
anti-myc was used to immunoprecipitate
myc-Upf1R(WT) or myc-Upf1R(G495R/
G497E) from HeLa cells as described earlier (Figure 1A). Western
blotting using anti-Upf1 revealed that myc-Upf1R(WT) and myc-
Upf1R(G495R/G497E) were immunoprecipitated with compara-
ble efficiencies, and mIgG failed to immunoprecipitate either pro-
tein (Figure 5A, lanes 3–6). Western blotting using anti-eIF3a
demonstrated that myc-Upf1R(G495R/G497E), relative to myc-
Upf1R(WT), immunoprecipitated the eIF3a subunit 3.5-fold
more efficiently (Figure 5A, lanes 4 and 6). Similarly, western blot-
ting using anti-eIF3 detected both eIF3a and eIF3b/c subunits,
suggesting that the entire eIF3 complex was associated with
Upf1. Consistent with this interpretation, anti-eIF3f, which reacts
more efficiently than anti-eIF3 with the integral f subunit of eIF3,
detected eIF3f in the IP of myc-Upf1R(G495R/G497E) (Figure 5A,
lanes 4 and 6). As expected if the increased reactivity of myc-
Upf1R(G495R/G497E) relative to myc-Upf1R(WT) with eIF3 was
due to Upf1 phosphorylation, myc-Upf1R(WT) from OA-treated320 Cell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc.
cells reacted 3-fold more strongly with eIF3 than did myc-
Upf1R(WT) from untreated cells (Figure 5B, lanes 4 and 6).
In the second test, HeLa cells were transfected with either
control or Upf1 siRNA. Two days later, cells were retransfected
with pmCMV-myc-Upf1R(G495R/G497E). Lysates were immu-
noprecipitated using anti-eIF3a or, to control for nonspecific
IP, mIgG. Western blotting using anti-eIF3a revealed that com-
parable amounts of eIF3a were immunoprecipitated regardless
of the siRNA treatment (Figure 5C, lanes 4 and 6). Western blot-
ting of samples before IP using anti-Upf1 showed that the abun-
dance of myc-Upf1R(G495R/G497E) was3-fold above the level
of cellular Upf1 in the presence of control siRNA (Figure 5C, lane
1), and Upf1 siRNA reduced the level of cellular Upf1 to 10% of
normal (Figure 5C, lane 2). However, western blotting of samples
after IP demonstrated that only myc-Upf1R(G495R/G497E) and
not endogenous Upf1 was immunoprecipiated (Figure 5C, lanes
4 and 6). As expected if the increased reactivity of eIF3a with
myc-Upf1R(G495R/G497E) relative to myc-Upf1R(WT) was due
to Upf1 phosphorylation, eIF3a reacted more strongly with
myc-Upf1R(WT) and cellular Upf1 when they derived from OA-
treated cells than when they derived from untreated cells (Fig-
ure 5D, lanes 4 and 6).
In the third test, equal amounts of baculovirus-produced
and purified FLAG-Upf1(WT) and FLAG-Upf1(G495R/G497E)
(Figure 5E) were used in far-western analyses to probe blots
of purified HeLa cell eIF3, bovine serum albumin (BSA) as a neg-
ative indicator, and two concentrations of FLAG-BAP to control
for variations in blotting and reactivity with anti-FLAG (Figure 5F,
left and right panels). In parallel, all three proteins were
subjected to Coomassie blue staining prior to blotting so that
they could be visualized and compared to far-western
results (Figure 5F, middle panel). We found that FLAG-
Upf1(G495R/G497E) had a 3-fold stronger affinity for eIF3a
than FLAG-Upf1(WT) under conditions where the reactivity of
FLAG-BAP with anti-FLAG was comparable (Figure 5F, com-
pare left and right panels). Furthermore, analyses of equal
amounts of purified baculovirus-produced FLAG-Upf1(WT) puri-
fied from virus-infected cells that were or were not treated with
OA (Figure 5G) revealed that OA treatment enhanced the reac-
tivity of FLAG-Upf1(WT) with eIF3a (Figure 5H, compare left
and right panels). Taken together, all of our findings suggest
that phospho-Upf1 promotes translational repression by binding
to eIF3.
Phospho-Upf1 Inhibits the Conversion of 40S-Bound
mRNA to 80S-Bound mRNA
If Upf1 phosphorylation promotes translational repression, then
baculovirus-produced FLAG-Upf1(WT) purified from OA-treated
insect cells and baculovirus-produced FLAG-Upf1(G495R/
G497E) purified from untreated insect cells would be expected
to inhibit mRNA translation in rabbit reticulocyte lysates (RRLs)
when compared to either baculovirus-produced FLAG-Upf1(WT)
from untreated insect cells or BSA. To test this prediction, cap-
ped and polyadenylated RLuc mRNA was synthesized in vitro
(Figure S6A) and added to RRLs that had been supplemented
with equal amounts of one of the three FLAG-Upf1 proteins
(Figure S6B, left panel), each of which manifested the expected
phosphorylation status (Figure S6B, right panel). Results re-vealed that FLAG-Upf1(WT) from OA-treated cells and FLAG-
Upf1(G495R/G497E) from untreated cells preferentially inhibited
the production of RLuc activity relative to either FLAG-Upf1(WT)
from untreated cells or BSA (Figure S6C). Furthermore, the ex-
tent of inhibition roughly correlated with the degree of Upf1 phos-
phorylation, although it is possible that not all Upf1 phosphoryla-
tion sites function equally in translational repression. These data
indicate that phospho-Upf1 inhibits RLuc mRNA translation
initiation in vitro.
If Upf1 phosphorylation promotes translational repression by
inhibiting eIF3 function, then phospho-Upf1 could preclude (1)
binding of the ternary complex to the 40S ribosomal subunit to
form the 40S/Met-tRNAi
Met preinitiation complex, (2) recruitment
of the preinitiation complex to mRNA, or (3) joining of the 60S
ribosomal subunit to the mRNA-bound preinitiation complex
to form the 80S/Met-tRNAi
Met/mRNA complex (Hinnebusch,
2006). To gain insight into how phospho-Upf1 inhibits translation
initiation, we used a so-called shift-assay (Darnbrough et al.,
1972). Briefly, in vitro-aminoacylated [35S]Met-tRNAi
Met was
added to elongation-inhibited RRLs to generate [35S]Met-la-
beled ternary complexes. The progressive association of ternary
complexes with 40S ribosomal subunits, mRNA, and, finally, 60S
ribosomal subunits was monitored using polysome profiling (Fig-
ure S7; Darnbrough et al., 1972). Shift assays were performed in
the presence of BSA, FLAG-Upf1(WT), or FLAG-Upf1(G495R/
G497E), which were added to RRLs prior to the addition of
charged [35S]Met-tRNAi
Met and in vitro-synthesized RLuc
mRNA (Figure 6A). Results revealed that, relative to either BSA
or FLAG-Upf1(WT), FLAG-Upf1(G495R/G497E) inhibited the for-
mation of 80S/[35S]Met-tRNAi
Met/mRNA initiation complexes
(Figures 6A and 6B).
In theory, the observed inhibition could be due to a block in ei-
ther the recruitment of preinitiation complexes to mRNA or the
joining of 60S ribosomal subunits to mRNA-bound preinitiation
complexes to form 80S/Met-tRNAi
Met/mRNA complexes. To dis-
tinguish between these two possibilities, the distribution of RLuc
mRNA in profiles was measured directly using RT-PCR. Results
revealed that while FLAG-Upf1(G495R/G497E) inhibited the for-
mation of 80S/Met-tRNAi
Met/mRNA complexes, there was no
significant effect on the recruitment of 40S/Met-tRNAi
Met to
mRNA (Figure 6C). Notably, using 0.1 M aurintricarboxylic acid
to prevent the binding of mRNA to 40S ribosomal subunits dem-
onstrated that ribosome-free RLuc mRNA sedimented in poly-
some gradients to a lighter region than 40S ribosomal subunits
(Figure S8). Thus, RLuc mRNA that sediments at 40S indeed rep-
resents true translation initiation complexes. We conclude that
phospho-Upf1 inhibits the joining of 60S ribosomal subunits to
mRNA-bound 40S initiation complexes.
DISCUSSION
Our studies have uncovered a previously unappreciated step of
translational repression during the process of mammalian cell
NMD. This step is triggered by Upf1 phosphorylation (Figure 7).
Data indicate that hypophosphorylated Upf1, which constitutes
the majority of cellular Upf1, is involved in early steps of the pio-
neer round of translation. These steps include translation termi-
nation since hypophosphorylated Upf1 has a stronger affiliationCell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc. 321
Figure 5. Upf1 Phosphorylation Promotes Upf1 Binding to eIF3 Subunits
(A) HeLa cells were transiently transfected with pCMV-myc-UPF1R(WT) or pmCMV-UPF1R(G495R/G497E). Western blotting (WB) was performed using the des-
ignated antibody (a) before () and after immunoprecipitation (IP) using anti-myc or mouse (m) IgG. The dot specifies a nonspecific band that does not interfere
with the analysis.
(B) HeLa cells were transiently transfected with pCMV-myc-UPF1R(WT) and treated with 0 or 75 nM OA for 3 hr prior to harvesting. Cell lysates were subjected to
western blot analysis before and after IP.
(C) HeLa cells were transiently transfected with control or Upf1 siRNA and 2 days later with pmCMV-UPF1R(G495R/G497E). Cell lysates were immunoprecipi-
tated using anti-eIF3a or mIgG, and western blotting was performed as noted.
(D) As in (B) except IP was performed using anti-eIF3a or mIgG.
(E) Coomassie blue staining of baculovirus-produced FLAG-Upf1(WT) and FLAG-Upf1(G495R/G497E).
(F) Far-western analysis (FW) of the specified purified proteins using baculovirus-produced FLAG-Upf1(WT) (left) or FLAG-Upf1(G495R/G497E) (right) followed by
western blotting using anti-FLAG. eIF3 subunits and BSA were also stained using Coomassie blue (middle).322 Cell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc.
than phospho-Upf1 for SMG-1 and eRF3 (Figure 1; Kashima
et al., 2006), all of which constitute the SURF complex that has
been proposed to function in nonsense codon recognition (Ka-
shima et al., 2006). Provided a post-splicing EJC exists more
than 25–30 nucleotides downstream of a termination event,
then Upf1 and SMG-1 of the SURF complex are thought to join
the EJC and Upf1 undergoes phosphorylation (Kashima et al.,
2006; Wittmann et al., 2006). Phospho-Upf1 has higher affinity
than hypophosphorylated Upf1 for eIF3 (Figure 5), so as to elicit
translational repression (Figures 2, 3, 4, 6, and S6). Phospho-
Upf1 also has a higher affinity for mRNA degradative activities
(Figure 1). We propose that the steps of translational repression
precede mRNA decay and, by precluding additional ribosome
loading and otherwise promoting mRNP remodeling, make the
NMD target physically accessible to degradative activities. While
we find that the rate of translation in RRLs in the presence of
phospho-Upf1 eventually returns to the rate in the presence
of hypophosphorylated Upf1 (Figure S6C), it should be noted
Figure 6. Phospho-Upf1 Inhibits the
Conversion of 40S/[35S]Met-tRNAi
Met/mRNA





G497E) were added to RRLs prior to the addition
of charged [35S]Met-tRNAi
Met and RLuc mRNA.
(A) [35S]Met was quantitated (colored plot) and
superimposed on absorbance profiles of subpoly-
somes and polysomes that were separated by su-
crose gradient centrifugation. The positions of 40S,
60S, and 80S complexes are specified.
(B) Superimposition of the [35S]Met distribution in
sucrose gradients of FLAG-Upf1(WT) or FLAG-
Upf1(G495R/G497E) as shown in (A).
(C) RT-PCR of RLuc mRNA in sucrose gradients.
that RRLs fail to recapitulate important
aspects of cellular metabolism, in-
cluding mRNA decay after translational
repression.
Evidence that phospho-Upf1 mediates
translational repression by inhibiting eIF3
function derives from the finding that
phospho-Upf1 has a higher affinity for
eIF3 than hypophosphorylated Upf1 (Fig-
ures 5 and S5). Furthermore, phospho-
Upf1 inhibits cap-dependent and HCV
IRES-dependent translation (Figures 4
and S6; data not shown), which rely on
eIF3, but not CrPV-dependent transla-
tion, which occurs independently of
eIF3 (Figure 4). Additionally, phospho-
Upf1 precludes the eIF3-mediated con-
version of 40S/Met-tRNAi
Met/mRNA to translationally competent
80S/Met-tRNAi
Met/mRNA (Figure 6). Consistent with phospho-
Upf1 mediating translational repression during NMD by targeting
eIF3, nonsense-containing mRNA that initiates translation in an
eIF3-independent mechanism using the CrPV IRES was found
to be immune to NMD (Figure 3). In contrast, a nonsense-con-
taining mRNA that initiates translation in an eIF3-dependent
mechanism using the EMCV IRES(GTTA) is subject to NMD
even though this IRES supports nearly the same level of transla-
tion as the CrPV IRES (Figure 3). While we do not know how
phospho-Upf1 binding to eIF3 inhibits eIF3 function, additional
support for eIF3 function during a pioneer round of translation
derives from the recent report that eIF3e, which is a nonessential
eIF3 subunit, is required for NMD (Morris et al., 2007).
The mechanism of translational repression during mammalian
cell NMD may overlap the more generalized type of translational
repression that is mediated in yeast by the decapping activator
Dhh1p (Coller and Parker, 2005). Rather than targeting an
(G) Coomassie blue staining of baculovirus-produced FLAG-Upf1(WT) from insect cells that were (+) or were not () treated with 75 nM OA for 3 hr prior to
harvesting.
(H) As in (F), except proteins shown in (G) were used as probes in the far-western analysis.Cell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc. 323
Figure 7. Model for Phospho-Upf1-Mediated Repression of Translation Initiation
Upf1, which is primarily hypophosphorylated, forms the SURF complex together with SMG-1, eRF1, and eRF3 when translation terminates during a pioneer
round, which involves CBP80/20-bound mRNA. If termination occurs sufficiently upstream of a post-splicing EJC, e.g., at the specified premature termination
codon (PTC), then Upf1 and SMG-1 associate with the EJC. Upon association, SMG-1 phosphorylates Upf1. Phospho-Upf1 then represses translation by binding
to eIF3 subunits and inhibiting the eIF3-mediated joining of 60S ribosomal subunits to 40S/Met-tRNAi
Met/mRNA. Phospho-Upf1 also recruits mRNA decay fac-
tors, including Dcp1a, Xrn1, and Rrp4.essential translation factor, data indicate that Dhh1p works to
promote the assembly of a translationally repressed mRNP
that is inaccessible to translation initiation factors. However, it
is possible that the phospho-Upf1-mediated inhibition of eIF3
function could be accompanied by the assembly of a translation-
ally repressed complex that, like the yeast complex, involves the
assembly of Lsm1-7 and other constituents. Consistent with this324 Cell 133, 314–327, April 18, 2008 ª2008 Elsevier Inc.possibility, downregulating Lsm1 inhibits the NMD of Gl and
GPx1 mRNAs (F. Lejeune and L.E.M., unpublished data). The
translational repression that typifies mammalian cell NMD un-
doubtedly results in mRNA sequestration away from ribosomes
and other components of the translational machinery, possibly in
P bodies (Parker and Sheth, 2007). This would allow physical ac-
cess of the mRNA to the decapping and 50-to-30 exonucleolytic
machinery, which functions during NMD in mammalian cells
(Lehner and Sanderson, 2004; Lejeune et al., 2003; Lykke-An-
dersen, 2002; Unterholzner and Izaurralde, 2004) and is enriched
in P bodies (Parker and Sheth, 2007). Consistent with the view
that phospho-Upf1 may deliver translationally repressed NMD
targets to sites of decapping and exonucleolytic decay, it was re-
cently reported that Upf1 dephosphorylation occurs in P bodies,
and a block in Upf1 dephosphorylation results in the accumula-
tion of Upf1, other NMD factors, and NMD substrates in P bodies




Cell Transfections, siRNA-Mediated Downregulation,
and Immunoprecipitations
HeLa CCl2 or Cos-7 cells were cultured in DMEM that was supplemented with
10% FBS (Invitrogen). When noted, cells were treated with siRNA as previously
reported (Kim et al., 2005). After 2 days, cells were transfected using Lipofect-
amine 2000 (Invitrogen) (Hosoda et al., 2006) with the specified plasmids and
harvested 1 day later. Where indicated, cells were incubated with 0, 50, or
75 nM OA (Sigma) 3 hr prior to harvesting. Protein was prepared using passive
lysis buffer (Promega), and RNA was purified using Trizol reagent (GIBCO-
BRL) before or after immunoprecipitation (Kim et al., 2005).
Western Blotting
Protein was electrophoresed in SDS-polyacrylamide, transferred to Hybond
ECL nitrocellulose (GE Healthcare), and probed (see Supplemental Data for
antibody details).
RT-PCR
FLuc, RLuc, Gl, and MUP mRNAs were amplified and analyzed as described
(Kim et al., 2005). R-Gl mRNA was amplified using 50-CCTGAGGA-
GAAGTCTGCCG-30 (sense) and 50-GGGTTTAGTGGTACTTGTGAGC-30 (anti-
sense).
Luciferase Activity Assays
Assays were performed using the Dual-Luciferase Reporter Assay System
(Promega) and a FB12 Luminometer (Berthold).
Far-Western Analyses
Blots of BSA (New England Biolabs), FLAG-BAP (Sigma), and purified eIF3
(Brown-Luedi et al., 1982) were probed with baculovirus-produced FLAG-
Upf1(G495R/G497E) or FLAG-Upf1(WT) purified from SF21 cells that either
were or were not treated with 75 nM of OA for 3 hr, and interactions were
detected using anti-FLAG (Hosoda et al., 2005).
In Vitro Synthesis of RLuc mRNA
To generate RLuc mRNA, phRL-CMV (Promega) was linearized using XbaI (NE




Calf liver tRNA (Clontech; 24 mg) was aminoacylated in vitro using 10 mg of pu-
rified His-tagged methionyl-tRNA synthetase (Stanley, 1974). Reactions
(200 ml) containing 500 mCi of [35S]Met (GE Healthcare, 37TBq/mmol), 10 mM
of unlabeled methionine, 40 mM Tris (pH 7.5), 15 mM MgCl2, 10 mM ATP,
and 1 U/ml of RNasin (Promega) were incubated for at 37C for 30 min (Pes-
tova and Hellen, 2001). They were subsequently extracted with acidic phenol
(pH 4.7), filtered using a Nuc-trap column (Invitrogen), and precipitated using
ethanol.In Vitro Shift Assays
Shift assays were performed essentially as described (Darnbrough et al., 1972)
and detailed in Supplemental Data.
SUPPLEMENTAL DATA
Supplemental Data include Results, Discussion, Experimental Procedures,
References, and eight figures and can be found with this article online at
http://www.cell.com/cgi/content/full/133/2/314/DC1/.
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